IRIS - Res&Arch Institutional Research Information System - Research & Archive

PARNETTI, Lucilla
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.884
EU - Europa 8.589
AS - Asia 7.869
SA - Sud America 1.564
AF - Africa 152
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 13
Totale 30.096
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.663
SG - Singapore 3.545
IE - Irlanda 1.740
UA - Ucraina 1.421
BR - Brasile 1.355
HK - Hong Kong 1.282
IT - Italia 1.282
CN - Cina 1.177
RU - Federazione Russa 996
VN - Vietnam 878
SE - Svezia 745
DE - Germania 724
FI - Finlandia 526
KR - Corea 362
GB - Regno Unito 274
FR - Francia 229
CA - Canada 122
IN - India 102
TR - Turchia 101
AT - Austria 99
PL - Polonia 93
AR - Argentina 85
RO - Romania 77
NL - Olanda 75
JP - Giappone 63
CH - Svizzera 60
MX - Messico 56
BD - Bangladesh 55
ZA - Sudafrica 50
IQ - Iraq 48
BE - Belgio 46
UZ - Uzbekistan 46
CZ - Repubblica Ceca 45
ES - Italia 43
ID - Indonesia 41
CO - Colombia 23
GR - Grecia 23
EC - Ecuador 22
LT - Lituania 21
PY - Paraguay 20
EG - Egitto 19
CL - Cile 17
PK - Pakistan 17
MA - Marocco 16
VE - Venezuela 15
AE - Emirati Arabi Uniti 14
LB - Libano 14
JO - Giordania 13
SA - Arabia Saudita 13
AU - Australia 12
KE - Kenya 12
NZ - Nuova Zelanda 12
PE - Perù 12
EU - Europa 11
DK - Danimarca 10
AM - Armenia 9
HR - Croazia 9
IR - Iran 9
AZ - Azerbaigian 8
DZ - Algeria 8
JM - Giamaica 8
NP - Nepal 8
TN - Tunisia 8
BG - Bulgaria 7
IL - Israele 7
KZ - Kazakistan 7
UY - Uruguay 7
AL - Albania 6
BO - Bolivia 6
PT - Portogallo 6
SK - Slovacchia (Repubblica Slovacca) 6
CR - Costa Rica 5
PA - Panama 5
PH - Filippine 5
RS - Serbia 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
BY - Bielorussia 4
GE - Georgia 4
LV - Lettonia 4
MD - Moldavia 4
SN - Senegal 4
TH - Thailandia 4
CI - Costa d'Avorio 3
CM - Camerun 3
CY - Cipro 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GM - Gambi 3
GT - Guatemala 3
HN - Honduras 3
IS - Islanda 3
KG - Kirghizistan 3
OM - Oman 3
PS - Palestinian Territory 3
SY - Repubblica araba siriana 3
TJ - Tagikistan 3
AO - Angola 2
BF - Burkina Faso 2
BH - Bahrain 2
Totale 30.043
Salva come PNG Salva come JPEG
Città #
Singapore 2.250
Chandler 1.967
Dublin 1.739
Hong Kong 1.268
San Mateo 850
Jacksonville 746
Boardman 682
Ashburn 537
Santa Clara 500
Dong Ket 479
Altamura 474
Medford 408
Princeton 402
Perugia 357
Wilmington 357
Seoul 356
Lawrence 355
Moscow 331
Beijing 289
Ann Arbor 259
Des Moines 248
Los Angeles 233
Munich 228
Andover 184
Ho Chi Minh City 148
New York 139
Piscataway 138
Helsinki 128
Saint Petersburg 121
São Paulo 108
The Dalles 96
San Paolo di Civitate 94
Falls Church 93
Turku 93
Hanoi 88
Norwalk 73
Woodbridge 67
Izmir 62
Warsaw 61
Nuremberg 60
Brooklyn 59
Denver 57
Tokyo 56
Redmond 54
Frankfurt am Main 52
Columbus 51
Dallas 51
Montreal 50
Houston 49
Chennai 45
Brussels 42
Rome 41
Stockholm 41
Belo Horizonte 40
Boston 38
Chicago 37
London 37
Shanghai 37
Bucharest 35
Timisoara 35
Atlanta 34
Rio de Janeiro 34
Poplar 33
Phoenix 32
Amsterdam 31
Johannesburg 31
Orem 30
Vienna 30
Toronto 29
Redwood City 27
Brasília 26
Curitiba 25
Manchester 25
San Francisco 25
Campinas 24
Mexico City 24
Guangzhou 22
Seattle 22
Tashkent 22
Baghdad 21
Lappeenranta 21
Den Haag 20
Charlotte 19
Hefei 19
Lausanne 19
Milan 19
Da Nang 18
Haiphong 18
Olomouc 18
Auburn Hills 17
Fairfield 17
Falkenstein 17
Naples 17
Fortaleza 15
Changsha 14
Frankfurt Am Main 14
Mumbai 14
Secaucus 14
Ankara 13
Brno 13
Totale 18.858
Salva come PNG Salva come JPEG
Nome #
CSF and blood biomarkers for Parkinson's disease 169
Apopoprotein-E genotype in normal aging, age-associated memory impairment, Alzheimer’s disease and vascular dementia patients 153
A new assay for antiphospholipid antibodies in patient with ischemic stroke 148
102.Evolutionary trends in carotid atherosclerotic plaques: results of a two-year follow-up study using an ultrasound imaging system. 135
Repeatable Battery for the Assessment of Neuropsychological Status: Italian Normative Data for Older Adults 134
Platelet MAO-B activity and vitamin B12 in old age dementias. 134
Effect of acetyl-L-carnitine on serum levels of cortisol and adrenocorticotropic hormone and its clinical effect in patients with senile dementia of Alzheimer type 132
First-ever stroke and outcome in patients admitted to Perugia Stroke Unit:predictors for death, dependency, and recurrence of stroke within the first three months. 126
a-D-Mannosidses in patients with familial Alzheimer's Disease 125
a-D-Mannosidases in patients with Alzheimer's disease 123
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients 117
Brain SPECT in pathological aging brain: Alzheimer's disease, mild cognitive impairment and age-associated cognitive impairment. 115
Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease. 115
Swalloving dysfunction: neurovascolar- anatomical correlation. 112
Time trends, frequency, characteristics and prognosis of short-duration transient global amnesia 111
Comparative kinetics of oxiracetam in serum and CSF of patients with dementia of Alzheimer type 109
99mTc-HMPAO-SPECT nell'invecchiamento cerebrale fisiologico, nei deficit di memoria età correlati e nella malattia di Alzheimer: studio longitudinale a un anno. 107
Diagnostic performance of a fully automated chemiluminescent enzyme immunoassay for Alzheimer's disease diagnosis 107
Hippocampal epileptogenesis in autoimmune encephalitis 107
Blood pressure and functional aspects of the aging brain. 106
Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementia. 105
Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies 105
Acetylcholinesterase and butyrylcholinesterase activity in cerebrospinal fluid of Alzheimer patients before and after 6-months treatment with donepezil. XXXI Congresso Società Italiana di Neurologia 104
[Whole blood filterability in chronic cerebrovascular disorders: effects of the use of buflomedil hydrochloride]. 104
The added value of Aβ42/Aβ40 in the CSF signature for routine diagnostics of Alzheimer's disease 104
99mTc-HMPAO cerebral SPECT in cerebrovascular disease with and without dementia. 103
Performance of Aβ1-40, Aβ1-42, Total Tau, and Phosphorylated Tau as Predictors of Dementia in a Cohort of Patients with Mild Cognitive Impairment. 103
Cerebrospinal fluid biomarkers in Parkinson disease. 103
Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies 103
Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI) 103
Brain SPECT in pathological aging brain: Alzheimer’s disease, mild cognitive impairment and age-associated cognitive impairment 102
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease 101
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment 101
A magnetization transfer study of mild and advanced Parkinson's disease. 101
Stroke related to carotid artery dissection in a young patient with Takayasu arteritis, systemic lupus erythematosus and antiphospholipid antibody syndrome. 100
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers. 100
1H-MRS, MRI-based hippocampal volumetry, and 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease. 100
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation 100
Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis 100
Neuropsychological results of long-term therapy with oxiracetam in DAT/MID patients in comparison with a control group 99
99mTc-HMPAO-SPECT contribution in the differential diagnosis of cognitive dysfunction. 98
Early admission to stroke unit influences clinical outcome 98
Dissecting the Interactions between Human Serum Albumin and α-Synuclein: New Insights on the Factors Influencing α-Synuclein Aggregation in Biological Fluids 98
Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis 98
Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementia. 97
B-mode imaging and histomorphometric evaluation of carotid atherosclerosis. 97
Expression of d-mannosidase in amyotrophic lateral sclerosis and Alzheimer's disease 96
Influence of dementia on antithrombotic therapy prescribed before stroke in patients with atrial fibrillation. 96
Brain SPECT in the diagnosis of degenerative dementia. 96
Cerebrospinal fluid lysosomal enzymes and α-synuclein in Parkinson's disease. 96
Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology 96
Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study 96
Neuroendocrine markers in aging brain: clinical and neurobiological significance of dexamethasone suppression test 95
Variazioni di attività della paraoxonasi serica nella fase acuta dello stroke ischemico. Stroke'99 Meeting on Cerebrovascular Diseases 95
Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies. 95
A combination of CSF Tau ratio and midsaggital midbrain-to-pons atrophy for the early diagnosis of progressive supranuclear palsy. 95
Risk factors and stroke subtypes: results of five consecutive years of the Perugia Stroke Registry 94
Is multi-infarct dementia representative of vascular dementias? A retrospective study 93
Cerebrospinal fluid biomarkers and white matter lesions: can we know more? 93
Cerebrospinal fluid acetylcholinesterase activity after long-term treatment with donepezil and rivastigmina. 93
Italian frontotemporal dementia network (FTD group-SINDEM): Sharing clinical and diagnostic procedures in Frontotemporal dementia in Italy 93
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis 93
Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease. 92
Lysosomal enzyme activities in human brain 92
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 92
Lysosomal enzyme activities as possible CSF biomarkers of synucleinopathies 92
Memantine reduces neuronal dysfunctions triggered by in vitro ischemia and 3-nitropropionic acid. 91
[Drinking-water and cardiovascular mortality]. 91
Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative. 91
Atrial fibrillation in patients with first-ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome 91
Cerebrospinal fluid beta-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies. 90
Association between migraine and headache attributed to stroke: a case-control study. 89
Abnormalities of resting-state EEG in patients with prodromal and overt dementia with Lewy bodies: Relation to clinical symptoms 89
A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy Bodies 89
Vascular cognitive impairment: a pragmatic concept 88
Atrial fibrillation and stroke. 88
Association of cerebral amyloid-β Aggregation with cognitive functioning in persons without dementia 88
Impulse Control Disorders and Levodopa-Induced Dyskinesias in Parkinson's Disease: Pulsatile versus Continuous Dopaminergic Stimulation 88
Abnormal cortical neural synchronization mechanisms in quiet wakefulness are related to motor deficits, cognitive symptoms, and visual hallucinations in Parkinson's disease patients: an electroencephalographic study 88
Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice 88
Phospholipid autoantibodies: time for a new immuno-assay? 87
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias. 87
Free water elimination improves test–retest reproducibility of diffusion tensor imaging indices in the brain: A longitudinal multisite study of healthy elderly subjects 87
Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease: protocol for a systematic review and individual participant data meta-analysis 87
Prevalence and risk of progression of preclinical Alzheimer's disease stages: A systematic review and meta-analysis 87
CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies. Phospho-Tau International Study Group. 86
Apolipoprotein-E genotype in normal aging, age-associated memory impairment, Alzheimer's disease and vascular dementia patients. 86
Efficacy of thrombolytic (rt-PA) therapy in old stroke patients: the Perugia Stroke Unit experience 85
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? 85
Serum anti-GFAP and anti-S100 autoantibodies in brain aging, Alzheimer's disease and vascular dementia. 85
Differences in Extracellular Matrix Production and Basic Fibroblast Growth Factor Response in Skin Fibroblasts from Sporadic and Familial Alzheimer’s Disease 85
Amyloid-β: a potential link between epilepsy and cognitive decline 85
Lysosomial hydrolase in cerebrospinal fluid from subjects with Parkinson's disease 84
Acetyl-L-carnitine in the treatment of mildly demented elderly patients. 84
[Effects of buflomedil hydrochloride on the rheological properties of the blood in chronic cerebrovascular diseases]. 84
Changes of olfactory tract in Parkinson’s disease: a DTI tractography study 84
Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement 84
Comparative kinetics of oxiracetam in serum and CSF of patients with dementia of Alzheimer type. 84
Activation of complement and contact system in Alzheimer’s disease 83
Posatirelin for the treatment of late-onset Alzheimer's disease: a double-blind multicentre study vs citicoline and ascorbic acid. 83
Totale 9.946
Salva come PNG Salva come JPEG
Categoria #
all - tutte 151.410
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 151.410
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.619 0 0 0 0 0 137 202 39 340 123 240 538
2021/20223.192 80 580 88 141 96 85 53 944 100 131 372 522
2022/20236.532 437 1.297 81 564 491 799 15 271 2.295 18 197 67
2023/20242.424 184 280 126 59 27 14 463 97 273 99 397 405
2024/20256.102 86 606 234 283 761 351 191 456 1.231 417 995 491
2025/20266.947 1.032 1.005 782 1.935 1.889 304 0 0 0 0 0 0
Totale 30.953